Is Modafinil a Controlled Substance? US, UK, Canada, and EU Status
Is modafinil a controlled substance or narcotic? Compare its Schedule IV status in the United States with prescription rules in the UK, Canada, and European Union.
17 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 17 of 17 clinical reviews.
Is modafinil a controlled substance or narcotic? Compare its Schedule IV status in the United States with prescription rules in the UK, Canada, and European Union.
Evidence-based guide to modafinil food and supplement interactions, including caffeine, grapefruit, St. John's wort, and timing with meals. prepared by the HealthRX.com Editorial Team.
Modafinil induces CYP3A4 and inhibits CYP2C19, lowering birth control and cyclosporine efficacy while raising levels of omeprazole, diazepam, and phenytoin.
A comprehensive review of modafinil (Provigil) safety signals, FDA regulatory actions, serious dermatologic reactions, psychiatric adverse events, and the rejected pediatric indication.
Standard adult modafinil starting dose is 200 mg each morning, up to 400 mg max. See timing for narcolepsy, shift work, OSA, and liver dose adjustments.
How to think about modafinil dosing in patients with chronic kidney disease, including FDA label guidance, what is known about metabolite handling, dialysis considerations, and a monitoring framework. Pending qualified clinical review.
Evidence-based safety guide for modafinil (Provigil) in adults aged 30-49, covering cardiovascular risk, drug interactions, psychiatric effects, and monitoring recommendations.
A clinician-level review of modafinil (Provigil) use in patients with autoimmune disease, covering pharmacology, immune interactions, drug-drug interactions with immunosuppressants, and monitoring protocols.
A deep dive into modafinil's long-term cardiovascular effects, covering blood pressure, heart rate, arrhythmia risk, and what the clinical evidence base does and does not establish in chronic users.
A deep dive into how modafinil (Provigil) affects cognitive function, covering mechanism, evidence quality by population, dosing considerations, risks, and who is most likely to benefit.
A physician-level comparison of compounded modafinil vs branded Provigil, covering FDA status, bioequivalence, cost, clinical trial data, and when each option may be appropriate.
A clinical comparison of Provigil (modafinil) pricing against armodafinil, pitolisant, solriamfetol, and traditional stimulants, with trial data, insurance coverage details, and practical switching guidance.
A guide to modafinil (Provigil) hair and skin changes, covering telogen effluvium, serious rash reactions, seborrheic dermatitis, and evidence-based management steps.
A complete timeline of modafinil (Provigil) from its 1974 synthesis in France through FDA approval, patent battles, and current clinical use for narcolepsy and shift-work disorder.
Learn how to safely stop modafinil (Provigil) with an evidence-based tapering protocol, withdrawal timeline, and clinical guidance from the HealthRX.com medical team.
A detailed history of modafinil (Provigil) manufacturing, FDA supply chain events, generic entry, and shortage timelines with clinical context and primary source citations.
A physician-level breakdown of how modafinil (Provigil) works, covering dopamine transporter inhibition, norepinephrine reuptake, histaminergic activation, orexin signaling, and GABA-glutamate modulation with full PubMed citations.